CURALEAF HOLDINGS, INC. Financials Curaleaf Holdings, Inc. Canadian Securities Exchange
Equities
CURA
CA23126M1023
Pharmaceuticals
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| - CAD | -.--% |
|
-10.77% | -10.46% |
| Apr. 22 | Curaleaf Brief: Completed Acquisition of Northern Green Canada | MT |
| Apr. 22 | Curaleaf Holdings, Inc. completed the acquisition of Northern Green Canada Inc.. | CI |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 2,995 | 7,932 | 6,327 | 3,084 | 3,052 | 3,657 | - | - |
| Enterprise Value (EV) 1 | 3,058 | 8,150 | 6,464 | 3,544 | 3,548 | 4,131 | 4,459 | 3,657 |
| P/E ratio | -42 x | -109 x | -59.6 x | -8.27 x | -10.7 x | -33.8 x | -77.4 x | 56.6 x |
| Yield | - | - | - | - | - | - | - | - |
| Capitalization / Revenue | 13.6 x | 12.7 x | 5.23 x | 2.31 x | 2.27 x | 2.59 x | 2.35 x | 2.06 x |
| EV / Revenue | 13.8 x | 13 x | 5.34 x | 2.65 x | 2.63 x | 2.93 x | 2.87 x | 2.06 x |
| EV / EBITDA | 118 x | 56.6 x | 21.7 x | 11.6 x | 11.6 x | 11.8 x | 10.8 x | 7.09 x |
| EV / FCF | -25.4 x | -71.5 x | -31.4 x | -38.5 x | 138 x | 65.7 x | 37.8 x | 26.7 x |
| FCF Yield | -3.94% | -1.4% | -3.19% | -2.59% | 0.73% | 1.52% | 2.65% | 3.74% |
| Price to Book | - | 4.84 x | 3.71 x | 2.41 x | 2.86 x | 4.13 x | - | - |
| Nbr of stocks (in thousands) | 476,001 | 662,968 | 707,979 | 717,322 | 734,220 | 738,403 | - | - |
| Reference price 2 | 6.293 | 11.96 | 8.937 | 4.300 | 4.156 | 4.953 | 4.953 | 4.953 |
| Announcement Date | 3/24/20 | 3/9/21 | 3/3/22 | 5/1/23 | 3/6/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 221 | 626.6 | 1,210 | 1,336 | 1,347 | 1,409 | 1,555 | 1,779 |
| EBITDA 1 | 25.9 | 144.1 | 298 | 305.4 | 304.5 | 351.3 | 413.1 | 515.5 |
| EBIT 1 | -27.72 | 63.68 | 175.6 | -12.37 | 42.88 | 132.9 | 204.5 | 333.5 |
| Operating Margin | -12.54% | 10.16% | 14.52% | -0.93% | 3.18% | 9.43% | 13.16% | 18.74% |
| Earnings before Tax (EBT) 1 | -45.79 | 22.04 | 64.8 | -226.4 | -124.4 | 55.89 | 112.3 | 264.3 |
| Net income 1 | -67.24 | -61.74 | -101.7 | -370.1 | -281.2 | -87.29 | -8.146 | 194.6 |
| Net margin | -30.42% | -9.85% | -8.41% | -27.69% | -20.88% | -6.19% | -0.52% | 10.94% |
| EPS 2 | -0.1500 | -0.1100 | -0.1500 | -0.5200 | -0.3900 | -0.1464 | -0.0640 | 0.0875 |
| Free Cash Flow 1 | -120.4 | -113.9 | -205.9 | -91.96 | 25.8 | 62.84 | 118 | 136.8 |
| FCF margin | -54.47% | -18.18% | -17.02% | -6.88% | 1.92% | 4.46% | 7.59% | 7.69% |
| FCF Conversion (EBITDA) | - | - | - | - | 8.47% | 17.89% | 28.57% | 26.54% |
| FCF Conversion (Net income) | - | - | - | - | - | - | - | 70.29% |
| Dividend per Share | - | - | - | - | - | - | - | - |
| Announcement Date | 3/24/20 | 3/9/21 | 3/3/22 | 5/1/23 | 3/6/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 317.1 | 320 | 313.1 | 337.6 | 339.7 | 352.5 | 336.5 | 338.6 | 333.2 | 345.3 | 339.6 | 348.2 | 353.9 | 364.7 | 365 |
| EBITDA 1 | 71.36 | 79.68 | 72.94 | 86.18 | 84.04 | 73.19 | 73.18 | 70.03 | 75.25 | 83.01 | 80.37 | 86.3 | 90.54 | 93.46 | 94.3 |
| EBIT 1 | 39.99 | 42.88 | 43.73 | 23.36 | 11.42 | -81.53 | 16.44 | -7.082 | 15.21 | 13.97 | 25.57 | 31.51 | 35.51 | 36.35 | 24.92 |
| Operating Margin | 12.61% | 13.4% | 13.97% | 6.92% | 3.36% | -23.13% | 4.89% | -2.09% | 4.57% | 4.05% | 7.53% | 9.05% | 10.03% | 9.97% | 6.83% |
| Earnings before Tax (EBT) 1 | 1.033 | 10.23 | 21.38 | 16.85 | -12.92 | -249.2 | -5.667 | -27.48 | -35.95 | -60.63 | 3.134 | 8.683 | 12.5 | 12.36 | 8.395 |
| Net income 1 | -56.92 | -27.54 | -19.98 | -28.34 | -51.48 | -260.3 | -54.38 | -71.24 | -92.35 | -63.23 | -35.82 | -33.07 | -30 | -30.59 | -36.74 |
| Net margin | -17.95% | -8.61% | -6.38% | -8.39% | -15.15% | -73.85% | -16.16% | -21.04% | -27.72% | -18.31% | -10.55% | -9.5% | -8.48% | -8.39% | -10.07% |
| EPS 2 | -0.0800 | -0.0400 | -0.0300 | -0.0400 | -0.0700 | -0.3600 | -0.0700 | -0.1000 | -0.1300 | -0.0900 | -0.0511 | -0.0478 | -0.0422 | -0.0433 | -0.0500 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 11/8/21 | 3/3/22 | 5/9/22 | 8/8/22 | 11/7/22 | 5/1/23 | 5/17/23 | 8/9/23 | 11/9/23 | 3/6/24 | - | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | 62.6 | 218 | 137 | 460 | 496 | 474 | 802 | - |
| Net Cash position 1 | - | - | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | 2.418 x | 1.513 x | 0.4589 x | 1.505 x | 1.628 x | 1.349 x | 1.941 x | - |
| Free Cash Flow 1 | -120 | -114 | -206 | -92 | 25.8 | 62.8 | 118 | 137 |
| ROE (net income / shareholders' equity) | -15.8% | -6.91% | -3.79% | -17.9% | -24.1% | -8.8% | 8.4% | 15.9% |
| ROA (Net income/ Total Assets) | -10.3% | -3.95% | -2.06% | -7.76% | -8.64% | -9% | - | - |
| Assets 1 | 653.4 | 1,562 | 4,930 | 4,771 | 3,256 | 969.9 | - | - |
| Book Value Per Share 2 | - | 2.470 | 2.410 | 1.780 | 1.450 | 1.200 | - | - |
| Cash Flow per Share 2 | -0.0800 | 0.0200 | -0.0500 | 0.0700 | 0.1300 | 0.1000 | 0.3600 | 0.5300 |
| Capex 1 | 82.1 | 126 | 172 | 138 | 65.4 | 62 | 60.2 | 115 |
| Capex / Sales | 37.13% | 20.15% | 14.22% | 10.35% | 4.86% | 4.4% | 3.87% | 6.46% |
| Announcement Date | 3/24/20 | 3/9/21 | 3/3/22 | 5/1/23 | 3/6/24 | - | - | - |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
C-
Sell
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
4.953
USD
Average target price
8.141
USD
Spread / Average Target
+64.38%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +109.78% | 2B | |
| +87.30% | 61.69M |
- Stock Market
- Equities
- CURA Stock
- CURA Stock
- Financials Curaleaf Holdings, Inc.
